Nerviano Medical Sciences (shanghai) Ltd.

This study tests an experimental drug, atamparib, in people with advanced non-small cell lung cancer (a common type of lung cancer) that has spread and stopped responding to standard treatments. The trial has two parts: first, finding the safest dose, then testing how well it wor…